Wednesday, January 19, 2022

RedHill Biopharma Ltd. (RDHL) Stock Continuously Rising, Here’s Why

RedHill Biopharma Ltd. (RDHL), a specialty biopharmaceutical company, has increased by 6.56% in the premarket trading session. As a result, RDHL stock is changing hands at $5.20 at the time of this writing. On Monday, RDHL stock rose 11.67% in regular trading session and closed the day at $4.88. The continuous rise of RDHL stock could presumably be related to the presentation of analysis about phase 2/3 data.


3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

Sponsored


RDHL reported data from the study

On Monday, RDHL reported new data from opaganib global Phase 2/3 study. The study was carried out in hospitalized patients with severe Covid-19. The study showed that the treatment with oral opaganib (ABC294640) as compared to placebo-controlled arm caused a reduction of 62% in mortality. Besides that, there was a significant improvement in time to room air and median time to hospital discharge in a group of 251 hospitalized. They were all moderately severe Covid-19 patients and comprised 53% of 475 study participants. The company said that the results were from a post-hoc analysis of data from 251 of the study participants; it required a fraction of inspired Oxygen up to 60% at the baseline. The patients having a fraction of inspired oxygen less than or equal to 60% were considered to be severely affected. They required oxygen supplementation. Mark L. Levitt, MD, PhD, Medical Director at RedHill, said that the findings support the potential for opaganib’s use in hospitalized, moderately severe COVID-19 patients.

RDHL stock Q2 2021 financial results


A Backdoor Way To Profit From Today’s Crypto Bull Market

Even if you’re not actively in crypto, you deserve to know what’s actually going on...

Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.

Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free. .

Sponsored


On 26th August, RDHL reported the quarterly results for the second quarter of the fiscal year 2021, which ended 30th June 2021. According to the details, the company generated net revenues of $21.50 million during the quarter. Compared to that, during the equivalent period of 2020, the net revenues stood at $20.89 million. The gross profit for three month period stood at $10.91 million, while during the equivalent period of 2020, it was $6.71 million. The total expenses for the period stood at $35.79 million. During the equivalent period of 2020, the total expenses were $19.21 million. The net loss for the period was $29.12 million (or $0.06 per basic and diluted share). Compared to that, the net loss for the equivalent three month period of 2020 was $16.04 million (or $0.04 per basic and diluted share). The company had cash and cash equivalents of $51.81 million on 30th June. The total stood at $203.67 million, while total liabilities were $174.09 million.

What’s ahead for RDHL?

Recent past performance indicators are revealing a grim picture for RDHL stock. The stock has declined by 51% during the last month, the primary reason being a failure in the performance of opaganib at various fronts. But as the recent study results have shown, RDHL stock could rise monumentally within the future based upon its innovation strategy.

Latest news

Looking Under The Hood: What’s Happening To Bee Vectoring Technologies (BEVVF) Stock

Bee Vectoring Technologies International Inc (BEVVF) closed up 24.71 percent on Wednesday at $0.3280, and has been trading in a day range of $0.2721...

Best cannabis stock investment could lead to great profits in the near future

In recent months, there has been much debate about which are the best cannabis stocks. There are several states where recreational marijuana is legal,...

Stealth BioTherapeutics Inc. (MITO) stock rose during after-hours, provided no current update.

Stealth BioTherapeutics Inc. (NASDAQ: MITO) stock plunged by 3.57% at last close whereas the MITO stock price gains by 6.17% in the after-hour trading...

CNFinance Holdings Ltd. (CNF) stock fell during after-hours, despite any current update.

CNFinance Holdings Ltd. (NASDAQ: CNF) stock declined by 20.27% in the after-hours trading session. CNFinance Holdings Limited is a significant provider of home equity...

Related news

Looking Under The Hood: What’s Happening To Bee Vectoring Technologies (BEVVF) Stock

Bee Vectoring Technologies International Inc (BEVVF) closed up 24.71 percent on Wednesday at $0.3280, and has been trading in a day range of $0.2721...

Best cannabis stock investment could lead to great profits in the near future

In recent months, there has been much debate about which are the best cannabis stocks. There are several states where recreational marijuana is legal,...

Stealth BioTherapeutics Inc. (MITO) stock rose during after-hours, provided no current update.

Stealth BioTherapeutics Inc. (NASDAQ: MITO) stock plunged by 3.57% at last close whereas the MITO stock price gains by 6.17% in the after-hour trading...

CNFinance Holdings Ltd. (CNF) stock fell during after-hours, despite any current update.

CNFinance Holdings Ltd. (NASDAQ: CNF) stock declined by 20.27% in the after-hours trading session. CNFinance Holdings Limited is a significant provider of home equity...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

1745

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

Download Free eBook For

7 GROWTH STOCKS FOR 2021

100% free. stop anytime no spam